The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy.
Xiuzhi DuanXiaoming XuBinbin YinBong HongWeiwei LiuQian LiuZhihua TaoPublished in: Journal of clinical laboratory analysis (2019)
Increased EphA3 expression is an independent prognostic factor for a poor outcome and decreased survival in PCa.